Srinivas Raghavan Viswanathan
8PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 27, 2026
An epigenetic bifunctional that toggles between transactivation and repression.Ananthan Sadagopan, Maximilian Carson, Eriks J Zamurs
|Dec 19, 2025
BCL-XL Dependence is a Subtype Agnostic Actionable Feature of Difficult-to-Treat Kidney Cancers.Tupa Basuroy, Treg Grubb, Ananthan Sadagopan
|Sep 15, 2025
Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma.Prathyusha Konda, Cary N Weiss, Yantong Cui
|Feb 06, 2025
Oncogenic TFE3 fusions drive OXPHOS and confer metabolic vulnerabilities in translocation renal cell carcinoma.Jiao Li, Kaimeng Huang, Meha Thakur
|Jan 14, 2023
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas.Omar Alhalabi, Jonathan Thouvenin, Sylvie Négrier
|Aug 23, 2022
How splicing confers treatment resistance in prostate cancer.Prathyusha Konda, Srinivas R Viswanathan
Pageof 2
Frequent Collaborators
4 joint publications
Toni K Choueiri
2 joint publications
Ziad Bakouny
2 joint publications
Jiao Li
2 joint publications
Prathyusha Konda
2 joint publications
Ananthan Sadagopan
2 joint publications
Eliezer M Van Allen
1 joint publications
David A Braun
1 joint publications
Cheng-Zhong Zhang
1 joint publications
Natalie Vokes
1 joint publications
Amin H Nassar
